文献速递结核与非结核分枝杆菌艾滋病与性传播感染细菌感染、耐药与抗菌药物

美国1998-2014年利福平耐药结核病分析

Rifampin-resistant Tuberculosis in the United States, 1998-2014.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该研究分析了美国1998-2014年国家结核病监测系统(除加州外)中培养阳性结核病例,发现利福平单耐药(RMR)占0.28%,HIV感染和既往结核史与RMR强相关,且RMR及获得性利福平耐药(ARR)均与死亡率升高相关。

要点

  • HIV感染合并既往结核者RMR风险显著升高(adjRR 25.9)。
  • RMR结核患者死亡率较药物敏感结核升高(adjRR 1.4)。
  • HIV感染者发生ARR风险显著高于无HIV者(adjRR 9.6)。

核心结论

  • 所有形式的利福平耐药均与HIV感染和死亡率增加正相关。

主要发现

  • 1998-2014年RMR结核病例中HIV感染者百分比每年下降4%。
  • HIV合并既往结核者RMR风险adjRR为25.9(95%CI 17.6-38.1),HIV无既往结核者adjRR为3.1(95%CI 2.4-4.1)。
  • RMR病例死亡率adjRR为1.4(95%CI 1.04-1.8)。
  • HIV感染者发生ARR的adjRR为9.6(95%CI 6.9-13.3),ARR与死亡率增加相关。

临床怎么用

  • 对HIV感染者及有既往结核史者应警惕利福平耐药,并关注其死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Monoresistance to rifamycins necessitates longer and more toxic regimens for tuberculosis (TB). We examined characteristics and mortality associated with rifampin-monoresistant (RMR) TB in the United States. METHODS: We analyzed Mycobacterium tuberculosis culture-positive cases reported to the National TB Surveillance System (excluding California) between 1998 and 2014. We defined RMR TB found on initial drug susceptibility testing and possible acquired rifampin-resistant (ARR) TB. We assessed temporal trends in RMR TB. For both classifications of rifampin resistance, we calculated adjusted risk ratios (adjRRs) and 95% confidence intervals (CIs) for characteristics associated with mortality when compared with drug-susceptible TB in multivariable models using backward selection. RESULTS: Of 180 329 TB cases, 126 431 (70%) were eligible for analysis, with 359 (0.28%) of eligible cases reported as RMR. The percentage of RMR TB cases with HIV declined 4% annually between 1998 and 2014. Persons with HIV and prior TB were more likely to have RMR TB (adjRR, 25.9; 95% CI, 17.6-38.1), as were persons with HIV and no prior TB (adjRR, 3.1; 95% CI, 2.4-4.1) vs those without either characteristic, controlling for other statistically significant variables. RMR cases had greater mortality (adjRR, 1.4; 95% CI, 1.04-1.8), controlling for HIV and other variables. Persons with HIV had greater risk of ARR than persons without HIV (adjRR, 9.6; 95% CI, 6.9-13.3), and ARR was also associated with increased mortality, controlling for HIV and other variables. CONCLUSIONS: All forms of rifampin resistance were positively associated with HIV infection and increased mortality.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sharling L, Marks SM, Goodman M, et al. Rifampin-resistant Tuberculosis in the United States, 1998-2014. Clin Infect Dis. 2020. PMID: 31233131. doi:10.1093/cid/ciz491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。